Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...
Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
Roku will be the first major streamer to use measurement firm iSpot's Outcomes at Scale metric in a bid to improve targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback